Skip to main content
×
×
Home

Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial

  • Valene H. L. See (a1) (a2), Emilie Mas (a1), Susan L. Prescott (a2) (a3), Lawrence J. Beilin (a1), Sally Burrows (a1), Anne E. Barden (a1), Rae-Chi Huang (a3) and Trevor A. Mori (a1)...
Abstract

Resolution of inflammation is an active process involving specialised pro-resolving mediators (SPM) generated from the n-3 fatty acids EPA and DHA. n-3 Fatty acid supplementation during pregnancy may provide an intervention strategy to modify these novel SPM. This study aimed to assess the effect of n-3 fatty acid supplementation in pregnancy on offspring SPM at birth and 12 years of age (12 years). In all, ninety-eight atopic pregnant women were randomised to 3·7 g daily n-3 fatty acids or a control (olive oil), from 20 weeks gestation until delivery. Blood was collected from the offspring at birth and at 12 years. Plasma SPM consisting of 18-hydroxyeicosapentaenoic acid (18-HEPE), E-series resolvins, 17-hydroxydocosahexaenoic acid (17-HDHA), D-series resolvins, 14-hydroxydocosahexaenoic acid (14-HDHA), 10 S,17S-dihydroxydocosahexaenoic acid, maresins and protectin 1, were measured by liquid chromatography-tandem MS. We identified the resolvins RvE1, RvE2, RvE3, RvD1, 17R-RvD1 and RvD2 for the first time in human cord blood. n-3 Fatty acids increased cord blood 18-HEPE (P<0·001) derived from EPA relative to the control group. DHA-derived 17-HDHA at birth was significantly increased in the n-3 fatty acid group relative to the controls (P=0·001), but other SPM were not different between the groups. n-3 Fatty acid supplementation during pregnancy was associated with an increase in SPM precursors in the offspring at birth but the effects were not sustained at 12 years. The presence of these SPM, particularly at birth, may have functions relevant in the newborn that remain to be established, which may be useful for future investigations.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial
      Available formats
      ×
Copyright
Corresponding author
* Corresponding author: Trevor A. Mori, fax +618 9224 0246, email trevor.mori@uwa.edu.au
Footnotes
Hide All

Equal senior authorship.

Footnotes
References
Hide All
1. Serhan, CN & Petasis, NA (2011) Resolvins and protectins in inflammation resolution. Chem Rev 111, 59225943.
2. Bannenberg, G & Serhan, CN (2010) Specialized pro-resolving lipid mediators in the inflammatory response: an update. Biochim Biophys Acta 12, 10.
3. Tabas, I (2010) Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 10, 3646.
4. Serhan, CN, Chiang, N, Dalli, J, et al. (2014) Lipid mediators in the resolution of inflammation. Cold Spring Harb Perspect Biol 7, a016311.
5. Mas, E, Croft, KD, Zahra, P, et al. (2012) Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 58, 14761484.
6. Morita, M, Kuba, K, Ichikawa, A, et al. (2013) The lipid mediator Protectin D1 inhibits influenza virus replication and improves severe influenza. Cell 153, 112125.
7. Lima-Garcia, JF, Dutra, RC, da Silva, K, et al. (2011) The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. Br J Pharmacol 164, 278293.
8. Huang, L, Wang, C-F, Serhan, CN, et al. (2011) Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. Pain 152, 557565.
9. Bento, AF, Claudino, RF, Dutra, RC, et al. (2011) Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol 187, 19571969.
10. Koltsida, O, Karamnov, S, Pyrillou, K, et al. (2013) Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. EMBO Mol Med 5, 762775.
11. Krishnamoorthy, N, Burkett, PR, Dalli, J, et al. (2015) Cutting edge: Maresin-1 engages regulatory T cells to limit type 2 innate lymphoid cell activation and promote resolution of lung inflammation. J Immunol 194, 863867.
12. de Paiva, CS, Schwartz, CE, Gjorstrup, P, et al. (2012) Resolvin E1 (RX-10001) reduces corneal epithelial barrier disruption and protects against goblet cell loss in a murine model of dry eye. Cornea 31, 12991303.
13. Dalli, J, Kraft, BD, Colas, RA, et al. (2015) Proresolving lipid mediator profiles in baboon pneumonia are regulated by inhaled carbon monoxide. Am J Resp Cell Mol 53, 314325.
14. Dalli, J, Ramon, S, Norris, PC, et al. (2015) Novel proresolving and tissue-regenerative resolvin and protectin sulfido-conjugated pathways. FASEB J 29, 21202136.
15. Jones, ML, Mark, PJ, Keelan, JA, et al. (2013) Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J Lipid Res 54, 22472254.
16. Keelan, JA, Mas, E, D’Vaz, N, et al. (2015) Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction 149, 171178.
17. Barker, DJP (2004) The developmental origins of adult disease. J Am Coll Nutr 23, Suppl. 6, 588S595S.
18. Dunstan, JA, Mori, TA, Barden, A, et al. (2004) Effects of n-3 polyunsaturated fatty acid supplementation in pregnancy on maternal and fetal erythrocyte fatty acid composition. Eur J Clin Nutr 58, 429437.
19. Dunstan, JA, Mori, TA, Barden, A, et al. (2003) Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomized, controlled trial. J Allergy Clin Immunol 112, 11781184.
20. Dunstan, JA, Mori, TA, Barden, A, et al. (2003) Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 33, 442448.
21. Denburg, JA, Hatfield, HM, Cyr, MM, et al. (2005) Fish oil supplementation in pregnancy modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 57, 276281.
22. Barden, AE, Mori, TA, Dunstan, JA, et al. (2004) Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy. Free Radic Res 38, 233239.
23. Dunstan, JA, Simmer, K, Dixon, G, et al. (2008) Cognitive assessment of children at age 2½ years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 93, F45F50.
24. Dunstan, JA, Roper, J, Mitoulas, L, et al. (2004) The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clin Exp Allergy 34, 12371242.
25. Dunstan, JA, Mitoulas, LR, Dixon, G, et al. (2007) The effects of fish oil supplementation in pregnancy on breast milk fatty acid composition over the course of lactation: a randomized controlled trial. Pediatr Res 62, 689694.
26. Olsen, SF, Dalby So̸rensen, J, Secher, NJ, et al. (1992) Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet 339, 10031007.
27. Onwude, JL, Lilford, RJ, Hjartardottir, H, et al. (1995) A randomised double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 102, 95100.
28. Salvig, JD, Olsen, SF & Secher, NJ (1996) Effects of fish oil supplementation in late pregnancy on blood pressure: a randomised controlled trial. Br J Obstet Gynaecol 103, 529533.
29. Mori, TA, Beilin, LJ, Burke, V, et al. (1997) Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease. Arterioscler Thromb Vasc Biol 17, 279286.
30. Mori, TA, Burke, V, Puddey, IB, et al. (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men. Am J Clin Nutr 71, 10851094.
31. Pottala, J, Espeland, M, Polreis, J, et al. (2012) Correcting the effects of −20 °C storage and aliquot size on erythrocyte fatty acid content in the Women’s Health Initiative. Lipids 47, 835846.
32. Mas, E, Croft, KD, Zahra, P, et al. (2012) Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 58, 14761484.
33. Barden, A, Mas, E, Croft, KD, et al. (2014) Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation. J Lipid Res 55, 24012407.
34. Weylandt, KH, Krause, LF, Gomolka, B, et al. (2011) Suppressed liver tumorigenesis in fat-1 mice with elevated omega-3 fatty acids is associated with increased omega-3 derived lipid mediators and reduced TNF-alpha. Carcinogenesis 32, 897903.
35. Isobe, Y, Arita, M, Matsueda, S, et al. (2012) Identification and structure determination of novel anti-inflammatory mediator resolvin E3, 17,18-dihydroxyeicosapentaenoic acid. J Biol Chem 287, 1052510534.
36. Endo, J, Sano, M, Isobe, Y, et al. (2014) 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload–induced maladaptive cardiac remodeling. J Exp Med 211, 16731687.
37. González-Périz, A, Planagumà, A, Gronert, K, et al. (2006) Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectin D1 and 17S-hydroxy-DHA. FASEB J 20, 25372539.
38. Chiu, CY, Gomolka, B, Dierkes, C, et al. (2012) Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis. Inflamm Res 61, 967976.
39. Prescott, SL, Barden, AE, Mori, TA, et al. (2007) Maternal fish oil supplementation in pregnancy modifies neonatal leukotriene production by cord-blood-derived neutrophils. Clin Sci 113, 409416.
40. Mori, T & Beilin, L (2004) Omega-3 fatty acids and inflammation. Curr Atheroscler Rep 6, 461467.
41. Mas, E, Barden, A, Burke, V, et al. (2015) A randomized controlled trial of the effects of n-3 fatty acids on resolvins in chronic kidney disease. Clin Nutr 35, 331336.
42. Mozurkewich, EL, Clinton, CM, Chilimigras, JL, et al. (2013) The mothers, omega-3, and mental health study: a double-blind, randomized controlled trial. Am J Obstet Gynecol 208, 313.e311313.e319.
43. Mozurkewich, E, Greenwood, M, Romero, V, et al. (2015) 792: EPA- and DHA-rich fish oil supplementation augments maternal and cord blood resolvin pathway markers: a mothers, omega-3, & mental health study secondary analysis. Am J Obstet Gynecol 212, S383S384.
44. Mor, G, Cardenas, I, Abrahams, V, et al. (2011) Inflammation and pregnancy: the role of the immune system at the implantation site. Ann N Y Acad Sci 1221, 8087.
45. Levy, BD, Kohli, P, Gotlinger, K, et al. (2007) Protectin D1 is generated in asthma and dampens airway inflammation and hyperresponsiveness. J Immunol 178, 496502.
46. Haworth, O, Cernadas, M, Yang, R, et al. (2008) Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol 9, 873879.
47. Aoki, H, Hisada, T, Ishizuka, T, et al. (2008) Resolvin E1 dampens airway inflammation and hyperresponsiveness in a murine model of asthma. Biochem Biophys Res Commun 367, 509515.
48. Rogerio, AP, Haworth, O, Croze, R, et al. (2012) Resolvin D1 and aspirin-triggered resolvin D1 promote resolution allergic airways responses. J Immunol 189, 19831991.
49. Connor, KM, SanGiovanni, JP, Lofqvist, C, et al. (2007) Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med 13, 868873.
50. Tungen, JE, Aursnes, M, Vik, A, et al. (2014) Synthesis and anti-inflammatory and pro-resolving activities of 22-OH-PD1, a monohydroxylated metabolite of protectin D1. J Nat Prod 77, 22412247.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords

Type Description Title
WORD
Supplementary materials

See et al supplementary material
Table S1

 Word (21 KB)
21 KB

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed